Han, Yuxuan
An, Yaling
Chen, Qian
Xu, Kun
Liu, Xueyuan
Xu, Senyu
Duan, Huixin
Vogel, Annette B.
Şahin, Uğur
Wang, Qihui http://orcid.org/0000-0003-3768-0401
Dai, Lianpan http://orcid.org/0000-0001-8352-1327
Gao, George F. http://orcid.org/0000-0002-3869-615X
Funding for this research was provided by:
National Key R&D Program of China
Article History
Received: 12 May 2022
Accepted: 24 August 2022
First Online: 14 September 2022
Competing interests
: Y.A., K.X., L.D, and G.F.G. are listed in the patent as the inventors of the prototype RBD-dimer as coronavirus vaccines. K.X., T.Z., L.D., and G.F.G. are listed in the patent as the inventors of chimeric Delta-Omicron RBD-dimer as coronavirus vaccine. U.Ş. is a management board member at BioNTech SE (Mainz, Germany) and U.Ş and A.B.V. are employees at BioNTech SE. A.B.V. and U.Ş. are inventors on patents and patent applications related to RNA technology and COVID-19 vaccines having securities from BioNTech SE. All other authors declare no competing interests.
Free to read: This content has been made available to all.